Federal Register Recent Federal Regulation Documents - Justia Regulation Tracker - Justia Regulations Trackerhttps://regulations.justia.com/regulations/fedreg/agencies/department-of-health-and-human-services/2019/10/03?limit=200®isters=between&mode=atom2024-05-17T15:43:16-07:00Justia Inchttps://www.justia.com/Justia Regulations Trackerhttps://regulations.justia.com/images/justiafedregulations.gifCopyright 2011 Justia Inchttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21526.htmlNotice - Teva Pharmaceuticals USA, Inc., et al.; Withdrawal of Approval of Five Abbreviated New Drug Applications for Pemoline Products; Correction2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21526Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21526.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21523.htmlNotice - Proposed Collection; 60-Day Comment Request; Autism Spectrum Disorder (ASD) Research Portfolio Analysis, NIMH2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21523Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21523.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21520.htmlNotice - Prospective Grant of an Exclusive Patent License: Compositions, Devices and Processes for Production and Delivery of Cell Grafts of Manufactured Retinal Pigment Epithelium Cell(s) Alone, or in Combination With Photoreceptor Cells, and on a Biodegradable Support Scaffold Transplanted Subretinally for Intra-Ocular Ophthalmic Treatment of Conditions of Degeneration, Dysfunction or Terminal Injury of Retinal Pigment Epithelium and/or Photoreceptors in Humans2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21520Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21520.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21519.htmlNotice - Prospective Grant of an Exclusive Patent License: Development and Commercialization of Cell Therapies for Cancer2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21519Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21519.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21518.htmlNotice - Announcement of Intent To Award Three OPDIV-Initiated Supplements for Grantees Under the Direct Services for Survivors of Torture Program2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21518Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21518.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21507.htmlNotice - Investigational Enzyme Replacement Therapy Products: Nonclinical Assessment; Guidance for Industry; Availability2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21507Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21507.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21506.htmlNotice - Further Testing of Donations That Are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry; Availability2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21506Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21506.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21491.htmlNotice - National Institute on Drug Abuse; Notice of Closed Meeting2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21491Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21491.pdfhttps://regulations.justia.com/regulations/fedreg/2019/10/03/2019-21490.htmlNotice - National Institute on Aging; Amended Notice of Meeting2019-10-03T00:00:00-07:002019-10-03T00:00:00-07:002019-21490Noticehttps://www.govinfo.gov/content/pkg/FR-2019-10-03/pdf/2019-21490.pdf